Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat with Carboplatin and Paclitaxel in Advanced NSCLC
NCT00481078Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2007
- Primary completion
- Jul 2009
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in non-small cell lung cancer (NSCLC) comparing Vorinostat + Chemo with Placebo + Chemo (2 arms). Primary endpoint: Response Rate. Started May 2007; status: completed.
02
Drugs
vorinostat
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00481078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00481078.